Is there an acquired form of cystic fibrosis, or a condition that closely mimics its respiratory and pancreatic manifestations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is There an Acquired Form of Cystic Fibrosis?

No, cystic fibrosis cannot be acquired—it is exclusively an autosomal recessive genetic disorder caused by mutations in both copies of the CFTR gene present from birth. 1

Why CF Cannot Be Acquired

  • CF is a genetic disease requiring biallelic CFTR mutations (mutations on both maternal and paternal chromosomes) that must be inherited at conception 1
  • The CFTR gene on chromosome 7q31.2 encodes a chloride channel protein essential for normal epithelial cell function 1
  • Over 1,950 CFTR mutations have been identified, with the F508del mutation accounting for 66-70% of CF alleles worldwide 1, 2
  • Birth prevalence is approximately 1/3,700 in the United States, with higher rates (1/2,500-3,500) among non-Hispanic whites 1

Conditions That Mimic CF Symptoms

While CF itself cannot be acquired, several conditions can produce strikingly similar respiratory and pancreatic manifestations:

Atypical CF and CFTR-Related Disorders

  • "Mild" CFTR mutations can produce monosymptomatic or late-onset disease that mimics acquired conditions 3, 4
  • Patients with compound heterozygous mutations (one severe mutation like F508del paired with a mild mutation like 5T polymorphism) may have minimal or no symptoms until adulthood 1
  • These individuals can present with isolated bronchiectasis, chronic sinusitis, or recurrent pancreatitis without classic CF features 4

Specific CFTR-Related Phenotypes That Appear "Acquired":

Congenital Bilateral Absence of Vas Deferens (CBAVD)

  • 78% of men with CBAVD have at least one CFTR mutation, with 46% having two identifiable mutations 1
  • These men typically have normal pulmonary and pancreatic function, presenting only with male infertility 1
  • The most common pairing is F508del with the 5T polymorphism (17% of CBAVD cases) 1

Late-Onset Pulmonary Disease

  • Patients with residual CFTR function can develop bronchiectasis and chronic bacterial infections in adulthood without prior CF diagnosis 4
  • These individuals may have been asymptomatic in childhood and appear to have "acquired" lung disease 3

Idiopathic Chronic Pancreatitis

  • CFTR mutations are associated with recurrent pancreatitis in adults without other CF manifestations 4
  • Patients maintain pancreatic sufficiency but experience episodic inflammation 4

Non-CF Conditions With Similar Presentations:

Primary Ciliary Dyskinesia

  • Produces chronic sinopulmonary disease with bronchiectasis similar to CF
  • Distinguished by absent or dysfunctional cilia rather than CFTR defects
  • Does not cause pancreatic insufficiency or elevated sweat chloride

Chronic Pancreatitis (Non-CFTR)

  • Alcohol-related, autoimmune, or hereditary pancreatitis can mimic CF pancreatic disease
  • Lacks respiratory symptoms and normal sweat chloride testing

Non-CF Bronchiectasis

  • Post-infectious, immunodeficiency-related, or idiopathic bronchiectasis produces similar respiratory symptoms
  • Sweat chloride testing (>60 mEq/L) definitively distinguishes CF from other causes 1, 5

Critical Diagnostic Distinction

The sweat chloride test remains the gold standard for distinguishing CF from CF-mimicking conditions:

  • Values >60 mEq/L confirm CF diagnosis 1, 5
  • Values 30-59 mEq/L in infants may require repeat testing 6, 5
  • Normal sweat chloride (<30 mEq/L) excludes classic CF but does not rule out CFTR-related disorders 1

Common Pitfall to Avoid

Do not assume adult-onset bronchiectasis or pancreatitis excludes CF—comprehensive CFTR genetic testing should be performed in patients with unexplained chronic sinopulmonary disease, bronchiectasis, or recurrent pancreatitis, as mild CFTR mutations can produce late-presenting phenotypes that appear "acquired" 3, 4, 7. The phenotypic spectrum extends far beyond classic childhood CF, and approximately 5% of the general population carries the 5T polymorphism that can act as a disease-causing mutation when paired with a severe CFTR mutation 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cystic Fibrosis: A Review.

JAMA, 2023

Research

Genotype and phenotype in cystic fibrosis.

Respiration; international review of thoracic diseases, 2000

Guideline

Guideline Summary: Abdominal Pain and Gastrointestinal Management in Children with Cystic Fibrosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Meconium Ileus in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Genetics of Cystic Fibrosis: Clinical Implications.

Clinics in chest medicine, 2016

Related Questions

What are three key facts about cystic fibrosis?
What are the key points to know about cystic fibrosis for the MRCP (Membership of the Royal College of Physicians) Part 1 UK exam?
Is it safe for a child with cystic fibrosis to play with another child who also has cystic fibrosis?
What maintenance therapy is recommended for a 14-year-old patient with a history of cystic fibrosis (CF), presenting with worsening chronic cough, increased sputum production, dyspnea, wheezing, digital clubbing, and apical crackles, due to a mutation affecting the cystic fibrosis transmembrane conductance regulator (CFTR) sodium chloride exchange channels?
What is the most appropriate action when a 7-year-old female with cystic fibrosis is playing with another child who also has cystic fibrosis?
Is a 5 mg dose of risperidone or aripiprazole sufficient as augmentation therapy for obsessive‑compulsive disorder?
Is Myfembree (relugolix 40 mg + estradiol 1 mg + norethisterone acetate 0.5 mg) appropriate to start in a woman with large intramural uterine fibroids who has failed levonorgestrel intrauterine system (IUS) and two months of dienogest and continues to have heavy menstrual bleeding lasting to day 25?
What is the recommended management for a corneal abrasion, including irrigation, prophylactic topical antibiotic drops, oral analgesics, cycloplegic drops, avoidance of patching, follow‑up timing, and criteria for urgent referral?
What is the appropriate evaluation and management for a 69‑year‑old man with hyperlipidemia, hypertension, type 2 diabetes mellitus, prostate cancer and a thyroid nodule who presents with hypothermia (temperature 94.8 °F) and ear pain?
In a patient being treated for community-acquired pneumonia who develops ventricular tachycardia after the first hospital day, what is the most likely initial explanation?
What is the appropriate management for a woman with a cervical swab positive for human papillomavirus but negative for malignancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.